M. Okada

Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) in urological malignancies: a multi-center retrospective study

Tetsuya Shindo, N. Masumori, Toshiaki Tanaka, 2021, Journal of Bone and Mineral Metabolism.

Who needs further evaluations to diagnose upper urinary tract urothelial cancers among patients with abnormal findings by enhanced CT?

F. Fukuta, S. Kato, Shunsuke Sato, 2015, Asian journal of urology.

Therapeutic options to reduce intravesical recurrence in newly diagnosed Ta high‐grade bladder cancer according to risk stratification: A multicenter retrospective study

N. Masumori, Toshiaki Tanaka, S. Hinotsu, 2021, International journal of urology : official journal of the Japanese Urological Association.

Dynamic changes of bone metastasis predict bone‐predominant status to benefit from radium‐223 dichloride for patients with castration‐resistant prostate cancer

Tetsuya Shindo, N. Nishiyama, N. Masumori, 2020, Cancer medicine.

Efficacy and safety of desmopressin orally disintegrating tablets 25 and 50 μg in male patients with nocturia: A Japanese real‐world multicenter clinical study

N. Shinkai, N. Masumori, J. Hashimoto, 2022, Lower urinary tract symptoms.

[A Case of Panperitonitis Caused by Spontaneous Bladder Rupture].

I. Takemasa, N. Masumori, Toshiaki Tanaka, 2020, Hinyokika kiyo. Acta urologica Japonica.

Prevention of local symptoms in muscle invasive bladder cancer patients: clinical significance of local radiation therapy

Tetsuya Shindo, N. Masumori, R. Kato, 2023, Supportive Care in Cancer.

Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy

Tetsuya Shindo, N. Masumori, R. Kato, 2024, AntiCancer Research.